COMPANY PROFILE // THE 014 REPORT
Telix Pharmaceuticals Ltd
TLX (Nasdaq) · TLPPF (OTC)
Assembled from 1 government source in 0.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.
Telix Pharmaceuticals Ltd is an SEC-registered company in pharmaceutical preparations, incorporated in Australia, based in North Melbourne, Australia; listed as TLX (Nasdaq), TLPPF (OTC).[source] It has filed 50 documents with the SEC in the last 12 months; the latest is Form 6-K, filed 2026-10-29.[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- CLEAR26
- POSSIBLE MATCH0
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Behrenbruch Christian · MD & Group CEO (Director,Officer) · latest Form 3 2026-03-18 · filing · LinkedIn search
- McDonald Marie Elizabeth · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
- Skinner Jann Elizabeth · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0002007191 | source |
| EIN | 00-0000000 | source |
| NY DOS IDpossible match | 7946353 | record |
| Connecticut business IDpossible match | 3438219 | record |
| Business address (SEC) | 55 FLEMINGTON ROAD, NORTH MELBOURNE, C3, 3051 | source |
Does not exist in the records we hold: LEI, UEI, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-04-30 · in 161 days · Next 20-F due (period ended 2026-12-31; Large accelerated filer) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-10-29 filing 6-K · SEC EDGAR
- 2026-10-21 filing 6-K · SEC EDGAR
- 2026-09-30 filing 6-K · SEC EDGAR
- 2026-09-21 filing 6-K · SEC EDGAR
- 2026-09-14 filing 6-K · SEC EDGAR
- 2026-09-02 filing 6-K · SEC EDGAR
- 2026-09-01 filing 6-K · SEC EDGAR
- 2026-08-20 filing 6-K · SEC EDGAR
- 2026-07-21 filing 6-K · SEC EDGAR
- 2026-07-02 filing 6-K · SEC EDGAR
- 2026-05-21 filing 6-K · SEC EDGAR
- 2026-04-23 filing UPLOAD · SEC EDGAR
- 2026-04-23 filing 6-K · SEC EDGAR
- 2026-04-21 filing 6-K · SEC EDGAR
- 2026-04-20 filing 6-K · SEC EDGAR
- 2026-04-17 filing CORRESP · SEC EDGAR
- 2026-04-14 filing 6-K · SEC EDGAR
- 2026-04-14 filing 6-K · SEC EDGAR
- 2026-04-13 filing 6-K · SEC EDGAR
- 2026-04-10 filing 6-K · SEC EDGAR
- 2026-04-09 filing 6-K · SEC EDGAR
- 2026-04-07 filing 6-K · SEC EDGAR
- 2026-04-03 filing UPLOAD · SEC EDGAR
- 2026-04-02 filing 6-K · SEC EDGAR
- 2026-03-20 filing 20-F/A · SEC EDGAR
- 2026-03-18 insider First Form 3/4/5 on record for Behrenbruch Christian (MD & Group CEO) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for McDonald Marie Elizabeth (Director) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Skinner Jann Elizabeth (Director) · SEC Forms 3/4/5
- 2026-03-16 filing 6-K · SEC EDGAR
- 2026-03-10 filing 6-K · SEC EDGAR
67 earlier entries
- 2026-02-20 filing F-3ASR
- 2026-02-20 filing Annual report (20-F)
- 2026-02-19 filing 6-K
- 2026-02-18 filing 6-K
- 2026-02-03 filing 6-K
- 2026-01-20 filing 6-K
- 2026-01-12 filing 6-K
- 2025-12-22 filing 6-K
- 2025-12-17 filing 6-K
- 2025-12-08 filing 6-K
- 2025-10-14 filing 6-K
- 2025-09-23 filing 6-K
- 2025-09-09 filing 6-K
- 2025-08-28 filing 6-K
- 2025-08-21 filing 6-K
- 2025-07-22 filing 6-K
- 2025-07-09 filing 6-K
- 2025-06-11 filing 6-K
- 2025-05-21 filing 6-K
- 2025-04-29 filing 6-K
- 2025-04-22 filing 6-K
- 2025-04-17 filing 6-K
- 2025-04-17 filing 6-K
- 2025-04-08 filing 6-K
- 2025-04-04 filing 6-K
- 2025-03-21 filing 6-K
- 2025-03-18 filing 6-K
- 2025-03-12 filing 6-K
- 2025-02-27 filing 6-K
- 2025-02-26 filing 6-K
- 2025-02-25 filing 6-K
- 2025-02-24 filing 6-K
- 2025-02-24 filing Annual report (20-F)
- 2025-02-21 filing 6-K
- 2025-02-13 filing 6-K
- 2025-01-31 filing 6-K
- 2025-01-27 filing 6-K
- 2025-01-17 filing 6-K
- 2025-01-13 filing 6-K
- 2025-01-13 filing 6-K
- 2024-12-30 filing 6-K
- 2024-12-19 filing S-8
- 2024-11-21 filing SEC STAFF LETTER
- 2024-11-19 filing 6-K
- 2024-11-14 filing 6-K
- 2024-11-12 filing EFFECT
- 2024-11-12 filing SEC STAFF ACTION
- 2024-11-12 filing CERT
- 2024-11-12 filing CORRESP
- 2024-10-30 filing 20FR12B/A
- 2024-10-28 filing SEC STAFF LETTER
- 2024-10-17 filing F-6
- 2024-10-17 filing CORRESP
- 2024-10-17 filing 20FR12B
- 2024-10-10 filing UPLOAD
- 2024-09-13 filing DRS
- 2024-06-14 filing RW
- 2024-06-14 filing RW
- 2024-06-10 filing 8-A12B
- 2024-06-05 filing F-1/A
- 2024-05-30 filing F-6
- 2024-05-17 filing F-1
- 2024-05-09 filing DRS/A
- 2024-04-15 filing DRS/A
- 2024-03-15 filing DRS/A
- 2024-02-02 filing DRS/A
- 2024-01-25 filing DRS
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-10-29 (within 30 days) 6-K filed
- 2026-10-21 (within 30 days) 6-K filed
- 2026-09-30 (older) 6-K filed
- 2026-09-21 (older) 6-K filed
- 2026-09-14 (older) 6-K filed
- 2026-09-02 (older) 6-K filed
- 2026-09-01 (older) 6-K filed
- 2026-08-20 (older) 6-K filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:TLX The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
5 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 2007191 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | TLX / Nasdaq, OTC | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Net income (loss) (fiscal year ended 2025-12-31) | -$7,125,000 | 2025-12-31 | 20-F, XBRL ProfitLoss | as filed | 2026-11-20 07:22 UTC | Report an error |
| Total assets (at 2025-12-31) | $1,163,986,000 | 2025-12-31 | 20-F, XBRL Assets | as filed | 2026-11-20 07:22 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | other | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-20 07:22 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-20 07:22 UTC | Report an error |
| State of incorporation | C3 | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-20 07:22 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-20 07:22 UTC | Report an error |
| Business address | 55 FLEMINGTON ROAD, NORTH MELBOURNE, C3, 3051 | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-20 07:22 UTC | Report an error |
| Exchanges | Nasdaq, OTC | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-20 07:22 UTC | Report an error |
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-10-29 Filing 6-K filed
- 2026-10-21 Filing 6-K filed
- 2026-09-30 Filing 6-K filed
- 2026-09-21 Filing 6-K filed
- 2026-09-14 Filing 6-K filed
- 2026-09-02 Filing 6-K filed
- 2026-09-01 Filing 6-K filed
- 2026-08-20 Filing 6-K filed
- 2026-07-21 Filing 6-K filed
- 2026-07-02 Filing 6-K filed
- 2026-05-21 Filing 6-K filed (CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS)
- 2026-04-23 Filing UPLOAD filed
- 2026-04-23 Filing 6-K filed (CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS)
- 2026-04-21 Filing 6-K filed (CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS)
- 2026-04-20 Filing 6-K filed (CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS)
- 2026-04-17 Filing CORRESP filed
- 2026-04-14 Filing 6-K filed
- 2026-04-14 Filing 6-K filed
- 2026-04-13 Filing 6-K filed (CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS)
- 2026-04-10 Filing 6-K filed
- 2026-04-09 Filing 6-K filed
- 2026-04-07 Filing 6-K filed
- 2026-04-03 Filing UPLOAD filed
- 2026-04-02 Filing 6-K filed (CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS)
- 2026-03-20 Filing 20-F/A filed
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
5 state and city records carry this company's exact name, from 3 sources. Possible matches only.
State licences (3)
possible match: matched by name only, not merged (3)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchTELIX PHARMACEUTICALS (US) INC · name equals 'Telix Pharmaceuticals' but other unrelated entities share it · sx:elic:ctcred:2980381 Compare
- possible matchTELIX PHARMACEUTICALS (US) INC · name equals 'Telix Pharmaceuticals' but other unrelated entities share it · sx:elic:ctcred:2536924 Compare
- possible matchTELIX PHARMACEUTICALS (US) INC · name equals 'Telix Pharmaceuticals' but other unrelated entities share it · sx:elic:ctcred:2292540 Compare
Connecticut business registrations (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchTELIX PHARMACEUTICALS (US) INC. · name equals 'Telix Pharmaceuticals' but other unrelated entities share it · sx:ctsos:3438219 Compare
New York corporations (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchTELIX PHARMACEUTICALS (US) INC. · name equals 'Telix Pharmaceuticals' but other unrelated entities share it · sx:nydos:7946353 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/2007191.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0002007191. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.